Table 4 of
Polisetty, Mol Vis 2008; 14:431-442. Table 4 of
Polisetty, Mol Vis 2008; 14:431-442.
Table 4. Surface antigen profile of MC-L and MSC-BM.
| Serial number | Marker | MC-L | MSC-BM |
|---|---|---|---|
| 1 | CD 34 | - (1.03±0.4) | - (0.19%±0.02) |
| 2 | CD45 | - (0.95%±0.43) | - (0.89%±0.2) |
| 3 | CD11a | - (0.28%±0.1) | - (0.87%±0.2) |
| 4 | CD11c | - (0.0%) | - (0.0%) |
| 5 | CD138 | - (0.98%±0.2) | - (1.35%±0.5) |
| 6 | CD106/VCAM | + (50.0% ±5.57) | + (54.67% ± 5.86) |
| 7 | CD105 | + (21.42% ± 4.133) | + (71.33% ± 6.66) |
| 8 | CD90 | + (95.63% ± 2.11) | + (94.57% ± 2.00) |
| 9 | CD29 | + (86.33% ± 3.06) | + (84.0% ± 2.65) |
| 10 | CD71 | + (66.07% ± 2.57) | + (45.27% ± 4.15) |
| 11 | HLA-ABC | + (93.44% ± 4.32) | + (91.33% ± 2.75) |
| 12 | HLA-DR | - (0.67%±0.1) | - (0.87%±0.14) |
| 13 | CD4 | - (0.99%±0.13) | - (0.15%±0.09) |
| 14 | CD8 | - (0.78%±0.15) | - (0.66%±0.12) |
| 15 | K3 | - (0.67%±0.27) | |
| 16 | K14 | - (0.95%±0.2) | |
| 17 | CD 68 | - (0.84%±0.43) | - (0.76%±0.025) |
| 18 | ICAM/CD54 | + (28.13% ± 4.01) | + (24.0% ± 4.58) |
| 19 | CD166 | + (81.67% ± 3.51) | + (83.67% ± 2.08) |
| 20 | CD31 | - (0.45± 0.23) | - (0.65% ±0.37) |
| 21 | CD14 | + (1.2%±0.43) | + (1.4%±0.5) |
| 22 | SSEA1 | - (0.00%) | |
| 23 | TRA-1–61 | - (0.00%) | |
| 24 | TRA-1–81 | - (0.00%) | |
| 25 | VE-Cadherin | - (0.00%) | |
| 26 | Flk1 | - (0.00%) | |
| 27 | Flt1 | - (0.00%) | |
| 28 | CD25 | - (0.64±0.24) | - (0.45±0.12) |